Both formats contain the same active ingredient semaglutide and produce similar results
Don't double up on doses to "catch up." If you frequently find yourself missing doses, it might be worth discussing with your healthcare provider whether your current schedule is realistic or if adjustments would be helpful
In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes
In some cases, it may cause breathing problems or gastrointestinal disturbances
A separate randomized trial investigated the mechanism directly (Sjdin et al., International Journal of Obesity , 2010
Kosmik excels for research-heavy writingAI content discovery finds relevant articles automatically, and visual organization helps with plot mapping